A genetically determined IL-6-dominated RA responds less well to anti-tumor necrosis factorore and work has to be done to provide reliable information regarding the functional aspects of these genetic polymorphisms. PubMed, Clin Rheumatol, 11/03/2015. (Also see Interleukins)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.